Article
Detecting copy number status and uncovering subclonal markers in heterogeneous tumor biopsies.
BMC genomics - 11 May 2011
Parisi Fabio, Ariyan Stephan, Narayan Deepak, Bacchiocchi Antonella, Hoyt Kathleen, Cheng Elaine, Xu Fang, Li Peining, Halaban Ruth, Kluger Yuval
Abstract excerpt
BACKGROUND: Genomic aberrations can be used to determine cancer diagnosis and prognosis. Clinically relevant novel aberrations can be discovered using high-throughput assays such as Single Nucleotide Polymorphism (SNP) arrays and next-generation sequencing, which typically provide aggregate signals of many cells at once. However, heterogeneity of tumor subclones dramatically complicates the task of detecting...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
